NanoDisc Platform Programs
Autoimmune Diseases (Type 1 Diabetes, Celiac, Lupus, MS)
PreclinicalActive
Key Facts
Indication
Autoimmune Diseases (Type 1 Diabetes, Celiac, Lupus, MS)
Phase
Preclinical
Status
Active
Company
About EVOQ Therapeutics
EVOQ Therapeutics is a private, preclinical-stage biotech founded in 2016, headquartered in Ann Arbor, Michigan, with a presence in San Diego. The company's breakthrough is the NanoDisc technology, a targeted antigen delivery system that aims to treat autoimmune diseases at their root cause by reprogramming the immune system. EVOQ has established significant partnerships with major pharmaceutical companies like Sanofi and Gilead and is advancing eight programs toward clinical development. Its approach promises enhanced efficacy with simple subcutaneous administration.
View full company profile